1. Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Intern Med 46, 771-774, 2007

2.Ishii W, Ito S, Kondo Y, Tsuboi H, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Okoshi Y, Hasegawa Y, Kojima H, Sakashita S, Aita K, Noguchi M, Sumida T.:
Intravascular large B-cell lymphoma with acute abdomen as a presenting symptom in a patient with systemic lupus erythematosus
J. Clin. Oncol. 26(9):1553-1555,2008

3.Horikoshi M, Ito S, Ishikawa M, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show reduced or insufficient response to infliximab.
Mod Rheumatol 19:229-234,2009

4. Kondo Y, Ito S,Ohi Y, Satou H, Hiraoka T, Tsuboi H, Sugihara M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Atypical Cogan's Syndrome with Aortitis.
Intern. Med 48:1093-1097,2009

5.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Sugihara M, Horikoshi M, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
New low-field extremity MRI, compacTscan: comparison with whole body 1.5 tesla conventional MRI.
Mod. Rheumatol. 20(4):331-336,2010

6.Sumida T, Tsuboi H, Iizuka M, Nakamura Y, Matsumoto I.:
Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjogren's syndrome.
Autoimmunity Reviews 9:615-617,2010

7.Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.:
New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren’s syndrome.
Clin. Exp. Immunol. 162:53-61, 2010

8.Horikoshi M, Suzuki T, Sugihara M, Kondo Y, Tsuboi H, Uehara T, Hama M, Takase K, Ohno S, Ishigatsubo Y, Yoshida Y, Sagawa A, Ikeda K, Ota T, Matsumoto I, Ito S, Sumida T.:
Comparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
Modern Rheumatology 20:556-560,2010

9.Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T.:
Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis.
J.Autoimmunity 35:383-389,2010

10.Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T, Ogishima H, Hayashi T, Goto D, Ito S, Matsumoto I, Sumida T.:
Importance of serine727 phosphorylated STAT1 in IFNgamma-induced signaling and apoptpsis of human salivary gland cells.
Int J Rheum Dis. 14:86-91,2011

11.Kondo Y, Iizuka M, Wakamatsu E, Yao Z, Tahara M, Tsuboi H, Sugihara M, Hayashi T, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
Overexpression of T-bet gene regulates murine autoimmune arthritis
Arthritis Rheum.64(1):162-172,2012

12.Tsuboi H, Nakamura Y, Iizuka M, Matsuo N, Matsumoto I, Sumida T.:
Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor
Mod. Rheumatol.22(2):264-271,2012

13.Tsuboi H, Matsuo N, Iizuka M, Tsuzuki S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
Analysis of IgG4 class switch-related molecules in IgG4-related disease.
Arthritis Res. Ther.14(4):R171,2012

14.Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Chino Y, Matsumoto I, Sumida T.:
Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor inhibitors: One year follow-up by low-field extremity MRI.
Mod. Rheumatol 23(4):782-7,2013

15.Sumida T, Iizuka M, Asashima H, Tsuboi H, Matsumoto I.：
Pathogenic role of anti-M3muscarinic acetylcholine receptor immune response in Sjogren's syndrome.
Presse Med.41(9 Pt 2):e461-6,2012

16..Iizuka M, Tsuboi H, Matsuo N, Kondo Y, Asashima H, Matsui M, Matsumoto I, Sumida T.:
The crucial roles of IFN-g in the development of M3 muscarinic acetylcholine receptor induced Sjogren's syndrome-like sialadenitis.
Mod. Rheumatol 23(3):614-6, 2013

17.Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I.:
Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren's syndrome.
Mod. Rheumatol 23(5): 841-5, 2013

18.Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tanaka Y, Tsuboi H, Suzuki T, Hayashi T, Ito S, Tsuchiya N, Sumida T.:
Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Clin. Exp. Immunol 172(1):44-53,2013

19.Tsuboi H, Hagiwara S, Asashima H, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
Validation of different sets of criteria for the diagnosis of Sjogren's syndrome in Japanese patients.
Mod. Rheumatol 23(2):219-25, 2013

20.Ogishima H, Tsuboi H, Naoto Umeda, Horikoshi M, Kondo Y, Sugihara M, Suzuki T, Matsumoto I, Sumida T:
Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis.
Mod Rheumatol(in press)

21.Hagiya C, Tsuboi H, Yokosawa M, Hagiwara S, Takai C, Hirota T, Asashima H, Miki H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Ogishima H, Suzuki T, Hiraoka T, Kaji Y, Matsumoto I, Ohshika T, Sumida T.:
Clinicopathological features of IgG4-related disease complicated with orbital involvement.
Mod Rheumatol 24(3):471-6,2014

22.Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T.:
Primary and secondary surveys on epidemiology of Sjogren's syndrome in Japan.
Mod Rheumatol 24(3):464-70,2014

23.Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I. :
The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: A Critical Review
J Autoimmunity 51:44-50,2014

24.Iizuka M, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
M3 muscarinic acetylcholine receptor reactive IL-17- producing T cells promotes development of Sjogren's syndrome like sialadenitis.
Mod Rheumatol 25(1):158-60, 2015

25.Sumida T, Tsuboi H, Asashima H, Iizuka M, Matsumoto I.:
Highlights from the 12th International Symposium on Sjogren's Syndrome in Kyoto, Japan.
Sjogren's Quarterly 9(1):8-14,2014

26.Hagiwara S, Tsuboi H, Hagiya C, Yokosawa M, Hirota T, Ebe H, Takahashi H, Ogishima H, Asashima H, Kondo Y, Umeda N, Suzuki T, Hitomi S, Matsumoto I, Sumida T.:
Pulmonary nocardiosis in patients with connective tissue disease: A report of two cases.
Intractable Rare Dis Res 3(1):25-28,2014

27.Segawa S, Goto D, Horikoshi M, Kondo Y, Umeda N, Hagiwara S, Yokosawa M, Hirota T, Miki H, Tsuboi H, Ogishima H, Suzuki T, Matsumoto I, Sumida T.：
Involvement of CD161+Vδ1+γδT cells in systemic sclerosis: Association with interstitial pneumonia.
Rheumatology(Oxford) 53(12):2259-69,2014

28.Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, Takai C, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida T.:
Clinical features of patients with IgG4-related disease complicated with perivascular lesions.
Mod Rheumatol 25(1):105-9,2015

29.Tsuboi H, Ohira H, Asashima H, Tsuzuki S, Iizuka M, Matsuo N, Kondo Y, Matsumoto I, Sumida T.:
Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis.
Hepatol Res 44(14):E471-9,2014

30.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T, Takaiwa F.:
Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis.
Biosci Biotech Bioch 78(10):1662-8,2014

31.Tsuboi H, Nakai Y, Iizuka M, Asashima H, Hagiya C, Tsuzuki S, Hirota T, Miki H, Hagiwara S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Yoshihara T, Abe K, Sumida T.:
DNA microarray analysis of labial salivary glands in IgG4-related disease. Comparison with Sjogren's syndrome.
Arthritis Rheum 66(10):2892-9,2014

32.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
Plant Biotechnol J 12:(8):1143-53,2014

33.Suzuki T, Hirota T, Ogishima H, Umeda N, Kondo Y, Yokosawa M, Miki H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for two years.
Int J Rheum Dis 18(1):108-10,2015

34.Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Hagiya C, Asashima H, Takai C, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy) trial. An open label, one-year, prospective study. Interim analysis of 32 patients for 24 weeks.
Mod Rheumatol 25(2):187-93,2015

35.Yokosawa M, Tsuboi H, Nasu K, Hagiya C, Hagiwara S, Hirota T, Ebe H, Takahashi H, Asashima H, Kondo Y, Ogishima H, Suzuki T, Minami M, Bukawa H, Matsumoto I, Sumida T.:
Usefulness of MR imaging of the parotid glands in patients with secondary Sjogren’s syndrome associated with rheumatoid arthritis.
Mod Rheumatol 25(3):415-20,2015

36.Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Satoru T, Sibayama S, Matsumoto I, Sumida T. :
T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice..
Clin Exp Immunol 179(2):197-209,2015

37.Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, Sumida T.:
Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan.
Mod Rheumatol 25(3):393-400,2015

38.Takahashi H, Tsuboi H, Kurata I, Takahashi H, Inoue S, Ebe H, Yokosawa M, Hagiwara S, Hirota T, Asashima H, Kaneko S, Kawaguchi H, Kurashima Y, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
Predictors of the response to treatment in acute lupus 1 hemophagocytic syndrome.
Lupus 24(7):659-68,2015

39.Furukawa S, Moriyama M, Tanaka A, Maehara T, Tsuboi H, Iizuka M, Hayashida J, Ohta M, Saeki T, Notohara K, Sumida T, Nakamura S.:
Polarized M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.
Clin Immunol 156(1):9-18,2015

40.Iizuka M, Tsuboi H, Matsuo N, Asashima H, Hirota T, Kondo Y, Iwakura Y, Takahashi S, Matsumoto I, Sumida T.:
A crucial role of RORgt in the development of spontaneous sialadenitis-like Sjogren's syndrome.
J Immunol 194(1):56-67,2015

41.Kurata I, Tsuboi H, Takahashi H, Inoue S, Ebe H, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Hoshi S, Oshika T, Sumida T.:
Successful treatment with infliximab for refractory uveitis in a patient with Behcet's disease on hemodialysis and a review of literature for infliximab use on hemodialysis.
Intern Med 54(12):1553-7,2015

42.Takahashi H, Tsuboi H, Ogishima H, Yokosawa M, Takahashi H, Yagishita M, Abe S, Hagiwara S, Asashima H, Umeda N, Kondo Y, Suzuki T, Matsumoto I, Sumida T.:
[18F]fluorodeoxyglucose positron emission tomography/computed tomography can reveal subclinical prostatitis in a patient with IgG4-related disease.
Rheumatology (Oxford) 54(6):1113,2015

43.Kurata I, Tsuboi H, Takahashi H, Yagishita M, Abe S, Ebe H, Takahashi H, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus
successfully treated by corticosteroid and methotrexate.
Rheumatology (Oxford) 54(7):1160,2015

44.Kondo Y, Yao Z, Tahara M, Izuka M, Yokosawa M, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumo I, Sumida T.:
Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice.
Arthritis Res Ther 17(1):105,2015

45.Asashima H, Tsuboi H, Iizuka M, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
The Anergy Induction of M3 Muscarinic Acetylcholine Receptor-Reactive CD4+ T Cells Suppresses Experimental Sialadenitis-like Sjogren's Syndrome.
Arthritis Rheum 67(8):2213-25,2015

46.Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K, Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.:
Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
PLoS One 10(5):e0126582,2015

47.Hirota T, Suzuki T, Ogishima H, Hagiwara S, Ebe H, Takahashi H, Yokosawa M, Umeda N, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Evaluation of changes in magnetic resonance images following 24 and 52 weeks treatment of rheumatoid arthritis with infliximab, tocilizumab or abatacept.
Mod Rheumatol 26(1):29-35,2016

48.Takahashi H, Tsuboi H, Abe S, Yokosawa M, Hagiwara S, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Magnetic resonance imaging can reveal fascial vasculitis in a patient with microscopic polyangiitis.
Scand J Rheumatol 44(6):511-3,2015

49.Umeda N, Matsumoto I, Kawaguchi H, Kurashima Y, Kondo Y, Tsuboi H, Ogishima H, Suzuki T, Kagami Y, Sakyu T, Ishigami A, Maruyama N, Sumida T.:
Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Clin Rheumatol 35(5):1181-8,2016

50.Tsuboi H, Sumida T, Noma H, Yamagishi K, Anami A, Fukushima K, Horigome H, Maeno Y, Kishimoto M, Takasaki Y, Nakayama M, Waguri M, Sago H, Murashima A.:
Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies.
Mod Rheumatol 26(4):569-75,2016

51.Miki H, Tsuboi H, Kaneko S, Takahashi H, Yokosawa M, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Nishimura B, Sugano M, Matsumoto I, Sumida T.:
A case of refractory Kimura disease with a buccal bulky mass successfully treated with
low-dose cyclosporine A: report and review of the literature.
Allergol Int 65(2):212-4,2016

52.Ohta M, Moriyama M, Maehara T, Gion Y, Furukawa S, Tanaka A, Hayashida J, Yamauchi M, Ishiguro N, Miakami Y, Tsuboi H, Iizuka-Koga M, Kawano S, Sato Y, Kiyoshima T, Sumida T, Nakamura S.:
DNA microarray analysis of submandibular glands in IgG4-related disease indicates a role for MARCO and other innate immune related proteins.
Medicine 95(7):e2853,2016

53.Hagiwara S, Tsuboi H, Honda F, Takahashi H, Kurata, I, Ohyama A, Yagishita M, Abe S, Kurashima Y, Kaneko S, Kawaguchi H, Takahashi H, Ebe H, Yokosawa M, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Association of anti-Ro/SSA antibody with response to biologics in patients with
rheumatoid arthritis.
Mod Rheumatol 26(6):857-862,2016

54.Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, Kondo Y, Ohta M, Wakasa Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of
glucose-6-phosphate-isomerase.
Mod Rheumatol 27(3):457-465,2017

55.Tahara M, Tsuboi H, Segawa S, Asashima H, Iizuka M, Hirota T, Takahashi H, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjogren's syndrome-like sialadenitis.
Clin Exp Immunol 187(2):213-224,2017

56.Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami HI, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T.:
A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.
Mod Rheumatol 27(5):849-854,2017

57.Yokosawa M, Kondo Y, Tahara M, Iizuka M, Segawa S, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
T-bet overexpression regulates AHR-mediated Th-17 differentiation through an IFNγ-independent pathway.
Clin Exp Immunol 188(1):22-35,2017

58.Abe S, Tsuboi H, Toko H, Honda F, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sakai S, Aonuma K, Sumida T.:
The effectiveness of upfront pulmonary vasodilators combination therapy in addition to corticosteroids for pulmonary arterial hypertension associated with systemic lupus erythematosus: two successful cases utilizing both corticosteroids and an upfront combination of vasodilators.
Modern Rheumatol Case Reports(in press)

59.Furukawa S, Moriyama N, Miyake K, Nakashima H, Tanaka A, Maehara T, Iizuka-Koga M, Tsuboi H, Hayashida JN, Ishiguro N, Yamauchi M, Sumida T, Nakamura S.:
Interleukin-33 produced by M2 macrophages and other immune cells contributes to immune reaction of IgG4-related disease.
Sci Rep 7:42413,2017

60.Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
Comparison of the performance of new ACR-EULAR classification criteria for primary Sjogren's syndrome with former sets of criteria in Japanese patients.
Ann Rheum Dis 76(12):1980-1985,2017

61.Iizuka-Koga M, Asashima H, Ando M, Lai C-Y, Mochizuki S, Nakanishi M, Nishimura T, Tsuboi H, Hirota T, Takahashi H, Masumoto I, Otsu M, Sumida T.:
Functional analysis of dendritic cells generated from T-iPS cells from CD4+ T cell clones of Sjogren's syndrome.
Stem Cell Reports 8(5):1155-1163,2017

62.Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
A case of recurrent Kikuchi-Fujimoto disease successfully treated by concomitant use of hydroxychloroquine and corticosteroid.
Intern Med 56(24):3373-3377,2017

63.Takahashi H, Tsuboi H, Asashima H, Hirota T, Kondo Y, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
Clin Exp Immunol 190(1):96-109,2017

64.Takahashi H, Tsuboi H, Yokosawa M, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjogren's syndrome associated with rheumatoid arthritis: Utility to evaluate and predict response to treatment.
Mod Rheumatol 28(2):300-307,2018

65.Kawaguchi H, Tsuboi H, Yagishita M, Terasaki T, Terasaki M, Shimizu M, Honda F, Ohyama A, Takahashi H, Miki H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
A case of severe adult-onset Still disease with constrictive pericarditis and pleuritis successfully treated with tocilizumab in addition to corticosteroid and cyclosporin A.
Intern Med 20(1):66,2018

66.Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mirori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T.
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
Mod Rheumatol 28(5):736-757,2018

67.Fujita-Tanaka H, Ogawa Y, Muro Y, Ogawa-Momohara M, Asashima H, Tsuboi H, Sumida T, Akiyama M.
Pansclerotic morphea associated with hypohidrosis and anti-M3 muscarinic acetylcholine receptor antibodies.
Br J Dermatol 178(3):e210-e211,2018

68.Ebe H, Matsumoto I, Kawaguchi H, Kurata I, Tanaka Y, Inoue A, Kondo Y, Tsuboi H, Sumida T.
Clinical and functional significance of STEAP4-splice variant in CD14⁺ monocytes in patients with rheumatoid arthritis.
Clin Exp Immunol 191(3):338-348,2018

69.Kondo Y, Yokosawa M, Kaneko S, Furuyama K, Segawa S, Tsuboi H, Matsumoto I, Sumida T.
Transcriptional regulation of CD4+ T cell differentiation in experimentally-induced arthritis and rheumatoid arthritis.
Arthritis Rheum 70(5):653-661,2018

70.Yagishita M, Kondo Y, Terasaki T, Terasaki M, Shimizu M, Honda F, Oyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.
A case of clinically amyopathic dermatomyositis with interstitial pneumonia successfully treated with plasma exchange.
Intern Med 57(13):1935-1938,2018

71.Kaneko S, Kondo Y, Yokosawa M, Furuyama K, Segawa S, Tsuboi H, Kanamori A, Matsumoto I, Yamazaki M, Sumida T.:
The RORgt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients.
Mod Rheumatol 28(5):814-825,2018

72.Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovsk? J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.:
Splicing variant of WDFY4 augments MDA5 signaling and the risk of clinically amyopathic dermatomyositis.
Ann Rheum Dis 77(4):602-611,2018

73.Honda F, Tsuboi H, Toko H, Terasaki T, Terasaki M, Shimizu M, Ohyama A, Yagishita M, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.
Contrast enhanced computed tomography revealed gallbladder hemorrhage due to active vasculitis in a patient with microscopic polyangiitis.
J Clin Rheumatol 25(6):e84-e85,2019

74.Takahashi H, Tsuboi H, Umeda N, Toko H, Honda F, Ohyama A, Abe S, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Hirose Y, Hara A, Sumida T.:
A case of otitis media with ANCA-associated vasculitis accompanied with pituitary mass successfully treated by corticosteroids.
Modern Rheumatol Case Reports 2(2)185-190,2018

75.Sumida T, Azuma N, Moriyama M, Takahashi H, Asashima H, Honda F, Abe S, Ono Y, Hirota T, Hirata S, Tanaka Y, Shimizu T, Nakamura H, Kawakami A, Sano H, Ogawa Y, Tsubota K, Ryo K, Saito I,Tanaka A, Nakamura S, Takamura E, Tanaka M, Suzuki K, Takeuchi T, Yamakawa N, Mimori T, Ohta A, Nshiyama,S Yoshihara T, Suzuki Y, Kawano M, Tomiita M, Tsuboi H.:
Clinical practice guideline for Sjogren's syndrome 2017.
Mod Rheumatol 28(3):383-408,2018

76.Toko H, Tsuboi H, Umeda N, Honda F, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
A case of intractable hemophagocytic syndrome associated with systemic lupus erythematosus resistant to corticosteroids and intravenous cyclophosphamide that was successfully treated by cyclosporine A.
Intern Med 57(18):2747-2752,2018

77.Shimizu M, Asashima H, Terasaki M, Toko H, Honda F, Ohyama A, Yagishita M, Takahashi H, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Renal sarcoidosis with multiple organ involvements.
J Clin Rheumatol 26(3):e55,2020

78.Ebe H, Matsumoto I, Osada A, Kurata I, Kawaguchi H, Kondo Y, Tsuboi H, Sumida T.:
Splice variant of STEAP4 localizes in the nucleus, making it a possible transcriptional regulator of IL-6 production.
Mod Rheumatol 29(4):714-716,2019

79.Shiraishi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazawaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T.
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study.
Sci Rep 8(1):10262,2018

80.Iizuka A, Segawa S, Kondo Y, Kaneko S, Yokosawa M, Furuyama K, Miki H, Tahara-Hanaoka S, Shibuya A, Tsuboi H, Goto D, Matsumoto I, Shibayama S, Sumida T.:
Allergy inhibitory receptor-1 inhibits autoantibody production via upregulation of apoptotic debris clearance by macrophages.
Int J Rheum Dis 21(12):2071-2078,2018

81.Segawa S, Kondo Y, Nakai Y, Iizuka A, Kaneko S, Yokosawa M, Furuyama K, Tsuboi H, Goto D, Matsumoto I, Sumida T.:
Placenta specific-8 suppresses IL-18 production through regulation of autophagy and is associated with Adult Still’s disease.
J Immunol 201(12):3535-3545,2018

82.Kawaguchi H, Matsumoto I, Osada A, Kurata I, Ebe H, Tanaka Y, Inoue A, Umeda N, Kondo Y, Tsuboi H, Ishigami A, Sumida T.:
Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interlukin-6.
Mod Rheumatol 29(6):964-969,2019

83.Kurata I, Tsuboi H, Terasaki M, Shimizu M, Toko H, Honda F, Ohyama A, Yagishita M, Osada A, Kaneko S, Ebe H, Kawaguchi H, Takahashi H, Hagiwara S, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
Effect of biological disease modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis.
Intern Med 58(12):1703-1712,2019

84.Tsuboi H, Iizuka-Koga M, Asashima H, Takahashi H, Kudo H, Ono Y, Honda F, Iizuka A, Segawa S, Abe S, Yagishita M, Yokosawa M, Kondo Y, Moriyama M, Matsumoto I, Nakaramura S, Sumida T.
Up-regulation and pathogenic roles of CCL18-CCR8 axis in IgG4-related disease.
Mod Rheumatol 30(4):729-737,2020

85.Kurata I, Matsumoto I, Ohyama A, Osada A, Ebe H, Kawaguchi H, Kaneko S, Kondo Y, Tsuboi H, Tomioka A, Kaji H, Sumida T.:
Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis.
Ann Rheum Dis 78(11):1488-1496,2019

86.Hagiwara S, Tsuboi H, Terasaki T, Terasaki M, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
Association of anti-cyclic citrullinated peptide antibody with clinical features in patients with psoriatic arthritis.
Mod Rheumatol 30(2):365-372,2020

87.Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H.:
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD.
Mod Rheumatol 30(3):551-557,2020

88.Tsuboi H, Honda F, Takahashi H, Ono Y, Abe S, Kondo Y, Matsumoto I, Sumida T.:
Pathogenesis of IgG4-related disease. Comparison with Sjogren's syndrome.
Mod Rheumatol 30(1):7-16,2020

89.Matsumoto I, Kurata I, Ohyama A, Kawaguchi H, Ebe H, Osada A, Kondo Y, Tsuboi H, Sumida T.:
Revisit of autoimmunity to glucose-6-phosphate isomerase in experimental and rheumatoid arthritis.
Mod Rheumatol 30(2):232-238,2020

90.Kudo H, Tsuboi H, Asashima H, Takahashi H, Ono Y, Abe S, Honda F, Kondo Y, Wakasa Y, Takaiwa F, Takano M, Matsui M, Matsumoto I, Sumida T.:
Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjogren's syndrome.
Mod Rheumatol 30(5):884-893,2020

91.Sato R, Takahashi H, Terasaki M, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Advantage of magnetic resonance imaging in detecting tracheal involvement and evaluation of the therapeutic effect in relapsing polychondritis with asthma-like symptoms.
J Clin Rheumatol (in press)

92.Terasaki M, Takahashi H, Sato R, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Successful treatment with multitarget therapy of mycophenolate mofetil and tacrolimus for cyclophosphamide-resistant ANCA-associated pauci-immune glomerulonephritis developed independently of systemic lupus erythematosus.
J Clin Rheumatol (in press)

93.Nishiyama T, Kondo Y, Okamoto S, Terasaki M, Toko H, Yagishita M, Takahashi H, Yokosawa M, Tsuboi H, Matsumoto I, Sumida T.:
Aortic arch aneurysm in Behcet disease successfully treated with infliximab.
Intern Med 59(8):1087-1091,2020

94.Ono Y, Tsuboi H, Moriyama M, Asashima H, Kudo H, Takahashi H, Honda F, Abe S, Kondo Y, Takahashi S, Nakamura S, Matsumoto I, Sumida T.:
RORγt antagonist improves Sjogren's syndrome-like sialadenitis through downregulation of CD25.
Oral Dis 26(4):766-777,2020

95.Imamura M, Mukaino A, Takamatsu K, Tsuboi H, Higuchi O, Nakamura H, Abe S, Ando Y, Matsuo H, Nakamura T, Sumida T, Kawakami A, Nakane S.:
Ganglionic acetylcholine receptor antibodies and autonomic dysfunction in autoimmune rheumatic diseases.
Int J Mol Sci 21(4):1332,2020

96.Okamoto S, Tsuboi H, Sato R, Terasaki T, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review.
Rheumatol Int 40(10):1725-1732,2020

97.Abe S, Tsuboi H, Kudo H, Asashima H, Ono Y, Honda F, Takahashi H, Yagishita M, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Identification of M3 muscarinic acetylcholine receptor reactive Th17 cells in patients with primary Sjogren's syndrome.
JCI insight 5(15):e135982,2020

98.Terasaki T, Kondo Y, Takahashi M, Tawara T, Fujita A, Yagi H, Kawai H, Noguchi M, Sato R, Terasaki M, Okamoto S, Toko H, Yagishita M,
Takahashi H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
Therapeutic plasma exchange improved pregnancy-associated thrombotic microangiopathy but not pregnancy outcome in patient with systemic lupus erythematosus.
Intern Med 59(24):3235-3238,2020

99.Tsuboi T, Suzuki H, Akutsu D, Terasaki T, Okamoto S, Kondo Y, Matsumoto I, Mizokami Y, Sumida T.:
The pathologically confirmed esophageal involvement of idiopathic multicentric Castleman’s disease mimicking early esophageal cancer.
Rheumatology(Oxford) (in press)

100.Yagishita M, Tsuboi H, Tabuchi D, Sugita T, Nishiyama T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Clinical features and prognosis of nocardiosis in patients with connective tissue diseases.
Mod Rheumatol (in press)

101.Osada A, Matsumoto I, Mikami N, Ohyama A, Kurata I, Kondo Y, Tsuboi H, Ishigami A, Sano Y, Arai T, Ise N, Sumida T.:
Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Clin Exp Immunol (in press)

102.Morinaka S, Tsuboi H, Hagiwara S, Sugita T, Tabuchi D, Sato R, Nishiyama T, Okamoto S, Terasaki T, Yagishita M, Takahashi H, Kondo Y, Matsumoto I, Sumida T.:
Clinical features of large vessel vasculitis (LVV): Elderly-onset versus young-onset.
Mod Rheumatol (in press)

103.Nishiyama T, Kondo Y, Tsuboi H, Noma H, Tabuchi D, Sugita T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Yagishita M, Abe S, Takahashi H, Osada A, Hagiwara S, Matsumoto I, Sumida T.:
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Mod Rheumatol (in press)

104.Takahashi H, Tsuboi H, Abe S, Honda F, Kondo Y, Matsumoto I, Sumida T.:
Humanized NOD/SCID/IL2rγnull mice exhibit functionally augmented human regulatory T cells associated with enzymatic upregulation of H3K27me3 in comparison with humans.
Clin Exp Immunol (in press)

105.Okamoto S, Kondo Y, Sato K, Nishiyama T, Toko H, Yagishita M, Yokosawa M, Tsuboi H, Ieda M, Matsumoto I.:
Anti-PL-7 antibody positive antisynthetase syndrome diagnosed after the onset of pulmonary hypertension and right-sided heart failure.
Rheumatology (in press)

106.Okamoto S, Tsuboi H, Noma H, Tabuchi D, Sugita T, Nishiyama T, Terasaki T, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Predictive factors for pneumomediastinum during management of connective tissue diseaserelated interstitial lung disease: A retrospective study.
Intern Med (in press)

107.Kurata I, Mikami N, Ohyama A, Osada A, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
Impaired function of PD-1+ follicular regulatory T cells in systemic lupus erythematosus.
Clin Exp Immunol (in press)

108.Ohyama A, Osada A, Kawaguchi H, Kurata I, Nishiyama T, Iwai T, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
Specific increase in joint neutrophil extracellular traps and its relation to interleukin 6 in autoimmune arthritis.
Int J Mol Sci (in press)

109.Honda F, Tsuboi H, Ono Y, Abe S, Takahashi H, Ito K, Yamada K, Kawano M, Kondo Y, Asano K, Tanaka M, Mallsen M, Mallsen B, Matsumoto I, Sumida T.:
Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis.
Arthritis Res Ther (in press)

110.Shimizu M, Kondo Y, Tanimura R, Furuyama K, Yokosawa M, Asashima H, Tsuboi H, Matsumoto I, Sumida T.:
T-bet represses collagen-induced arthritis by suppressing Th17 lineage commitment through inhibition of RORgt expression and function.
Sci Rep (in press)

111.Furuyama K, Kondo Y, Shimizu M, Yokosawa M, Segawa S, Iizuka A, Tanimura R, Tsuboi H, Matsumoto I, Sumida T.:
RORγt⁺Foxp3⁺ regulatory T cells in the regulation of autoimmune arthritis.
Clin Exp Immunol (in press)